22 results
8-K
EX-99.1
KNTE
Kinnate Biopharma Inc
18 Sep 23
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
4:28pm
timelines. We believe that reprioritizing our programs is the most effective approach to unlock the full promise of our innovative therapies.”
Farzan added
10-Q
tg85x hpm5m4huc
17 May 21
Quarterly report
4:26pm
8-K
EX-99.1
psx8vk5y1m4ev
13 May 21
Kinnate Biopharma Inc. Closes $35 Million Series A Financing
4:18pm
10-K
t1p fgtzz22lnj
29 Mar 21
Annual report
4:26pm
424B4
26myvstt
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
6xizdnpweulbcqs0
30 Nov 20
IPO registration (amended)
6:05am
S-1
tdx5pft2u7
13 Nov 20
IPO registration
5:03pm
DRS/A
h7s75r
3 Nov 20
Draft registration statement (amended)
12:00am